PET/MRI in head and neck cancer: initial experience

Area of Science:

• Oncology
• Radiology
• Nuclear Medicine

Background:

• Head and neck cancers require accurate initial staging for effective treatment planning.
• Conventional imaging techniques may have limitations in fully characterizing the extent of disease.

Purpose of the Study:

• To assess the feasibility of using integrated positron emission tomography/magnetic resonance imaging (PET/MRI) with fluorodeoxyglucose (FDG) for the initial staging of head and neck cancers.
• To compare the diagnostic performance of PET/MRI with conventional PET and MRI alone.

Main Methods:

• A cohort of 20 patients with histologically confirmed head and neck squamous cell carcinoma underwent both conventional PET and whole-body PET/MRI scans.
• FDG was administered intravenously prior to imaging.
• Tumor and cerebellar maximum standardized uptake values (SUVmax) and lymph node uptake were analyzed and compared between imaging modalities.

Main Results:

• PET/MRI demonstrated no MRI-induced artifacts, maintaining PET and MR image quality.
• The hybrid PET/MRI approach detected tumors in more patients (17/20) compared to conventional PET (16/20) and MRI (14/20).
• PET/MRI yielded significantly higher SUVmax for tumors and cerebellum and detected a significantly greater number of lymph nodes with increased FDG uptake than conventional PET.

Conclusions:

• Whole-body PET/MRI is a feasible imaging technique for the initial staging of head and neck cancer.
• The integrated PET/MRI system offers improved detection capabilities for both primary tumors and lymph node metastases without compromising image quality.